12:00 AM
 | 
Dec 10, 2012
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Cel-Sci completes direct public offering

Cel-Sci Corp. (NYSE-M:CVM), Vienna, Va.
Business: Cancer, Infectious
Date completed: 12/4/12
Type: Direct public offering...

Read the full 51 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >